Changes in Quality of Life following Buprenorphine Treatment: Relationship with Treatment Retention and Illicit Opioid Use

REFERENCES

• Baharom, N.; Hassan, M.R.; Ali, N. & Shah, S.A. 2012. Improvement of quality of life following 6 months of methadone maintenance therapy in Malaysia. Substance Abuse Treatment, Prevention, and Policy 7: 32.
   PubMed Web of Science ®Google Scholar
• Bates, D.; Maechler, M. & Bolker, B. 2012. lme4: Linear mixed-effects models using S4 classes. R package version 0.999999-0. Available at http://CRAN.R-project.org/package=lme4
   Google Scholar
• Chand, P.K.; Mattoo, S.K. & Sharan, P. 2004. Quality of life and its correlates in patients with bipolar disorder stabilized on lithium prophylaxis. Psychiatry and Clinical Neurosciences 58(3): 311–318.
   PubMed Web of Science ®Google Scholar
• Chou, Y.C.; Shih, S.F.; Tsai, W.D.; Li, C.S.; Xu, K. & Lee, T.S. 2013. Improvement of quality of life in methadone treatment patients in northern Taiwan: A follow-up study. BMC Psychiatry 13: 190.
   PubMed Web of Science ®Google Scholar
• Cohen, J.; Cohen, P.; West, S.G. & Aiken, L.S. 2003. Applied Multiple Regression/Correlation Analysis for the Behavioral Sciences, 3rd ed. Mahwah, NJ: Erlbaum.
   Google Scholar
• Darke, S.; Hall, W.; Wodak, A.; Heather, N. & Ward, J. 1992. Development and validation of a multi-dimensional instrument for assessing outcome of treatment among opiate users: The Opiate Treatment Index. British Journal of Addiction 87(5): 733–742.
   PubMedGoogle Scholar
• Den Oudsten, B.L.; Zijlstra, W.P. & De Vries, J. 2013. The minimal clinical important difference in the World Health Organization Quality of Life instrument: 100. Supportive Care in Cancer 21(5): 1295–1301.
   PubMed Web of Science ®Google Scholar
• Dhawan, A. & Chopra, A. 2013. Does buprenorphine maintenance improve the quality of life of opioid users? Indian Journal of Medical Research 137(1): 130–135.
   PubMed Web of Science ®Google Scholar
• Fudala, P.J.; Bridge, T.P.; Herbert, S.; Williford, W.O.; Chiang, C.N.; Jones, K.; Collins, J.; Raisch, D.; Casadonte, P.; Goldsmith, R.J.; Ling, W.; Malkerneker, U.; McNicholas, L.; Renner, J.; Stine, S.; Tusel, D. & the Buprenorphine/Naloxone Collaborative Study Group. 2003. Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone. New England Journal of Medicine 349(10): 949–958.
   PubMed Web of Science ®Google Scholar
• Giacomuzzi, S.M.; Ertl, M.; Kemmler, G.; Riemer, Y. & Vigl, A. 2005. Sublingual buprenorphine and methadone maintenance treatment: A three-year follow-up of quality of life assessment. The Scientific World Journal 5: 452–468.
   Web of Science ®Google Scholar
• Giri, O.P.; Srivastava, M. & Shankar, R. 2013. Quality of life and its correlates among substance dependent subjects: A study from a tertiary care centre in northeastern part of India. International Journal of Medicine and Medical Sciences 3(6): 464–469.
   Google Scholar
• Gryczynski, J.; Mitchell, S.G.; Jaffe, J.H.; O’Grady, K.E.; Olsen, Y.K. & Schwartz, R.P. 2014. Leaving buprenorphine treatment: Patients’ reasons for cessation of care. Journal of Substance Abuse Treatment 46(3): 356–361.
   PubMed Web of Science ®Google Scholar
• Ha, N. 2010. The effect of methadone maintenance treatment in improvement of quality of life for heroin users in Hai Phong, Vietnam. Paper presented at the The 4th International Conference on Reproductive Health and Social Sciences Research, Bangkok, Thailand.
   Google Scholar
• Hawthorne, G.; Herrman, H. & Murphy, B. 2006. Interpreting the WHOQOL-BREF: Preliminary population norms and effect sizes. Social Indicators Research 77: 37–59.
   Web of Science ®Google Scholar
• Hothorn, T.; Bretz, F.; Westfal, P.; Heiberger, R. & Schuetzenmeister, A. 2013. Multcomp: Simultaneous inference in general parametric models (Version 1.2-15) [Computer software].
   Google Scholar
• Jaeschke, R.; Singer, J. & Guyatt, G.H. 1989. Measurement of health status: Ascertaining the minimal clinically important difference. Controlled Clinical Trials 10(4): 407–415.
   PubMedGoogle Scholar
• Johnson, R.E.; Eissenberg, T.; Stitzer, M.L.; Strain, E.C.; Liebson, I.A. & Bigelow, G.E. 1995. A placebo controlled clinical trial of buprenorphine as a treatment for opioid dependence. Drug and Alcohol Dependence 40(1): 17–25.
   PubMed Web of Science ®Google Scholar
• Johnson, R.E.; Jaffe, J.H. & Fudala, P.J. 1992. A controlled trial of buprenorphine treatment for opioid dependence. JAMA 267(20): 2750–2755.
   PubMed Web of Science ®Google Scholar
• Karow, A.; Verthein, U.; Pukrop, R.; Reimer, J.; Haasen, C.; Krausz, M. & Schafer, I. 2011. Quality of life profiles and changes in the course of maintenance treatment among 1,015 patients with severe opioid dependence. Substance Use & Misuse 46(6): 705–715.
   PubMed Web of Science ®Google Scholar
• Kosinski, M.; Zhao, S.Z.; Dedhiya, S.; Osterhaus, J.T. & Ware, J.E. Jr. 2000. Determining minimally important changes in generic and disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis. Arthritis & Rheumatology 43(7): 1478–1487.
   PubMed Web of Science ®Google Scholar
• Latkin, C.A.; Sherman, S. & Knowlton, A. 2003. HIV prevention among drug users: Outcome of a network-oriented peer outreach intervention. Health Psychology 22(4): 332–339.
   PubMed Web of Science ®Google Scholar
• Lauridsen, H.H.; Hartvigsen, J.; Manniche, C.; Korsholm, L. & Grunnet-Nilsson, N. 2006. Responsiveness and minimal clinically important difference for pain and disability instruments in low back pain patients. BMC Musculoskeletal Disorders 25(7): 82.
   Web of Science ®Google Scholar
• Ling, W.; Farabee, D.; Liepa, D. & Wu, L.T. 2012. The Treatment Effectiveness Assessment (TEA): An efficient, patient-centered instrument for evaluating progress in recovery from addiction. Substance Abuse and Rehabilitation 3(1): 129–136.
   PubMedGoogle Scholar
• Maremmani, I.; Pani, P.P.; Pacini, M. & Perugi, G. 2007. Substance use and quality of life over 12 months among buprenorphine maintenance-treated and methadone maintenance-treated heroin-addicted patients. Journal of Substance Abuse Treatment 33(1): 91–98.
   PubMed Web of Science ®Google Scholar
• Mattick, R.P.; Breen, C.; Kimber, J. & Davoli, M. 2009. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database of Systematic Reviews 3: CD002209.
   PubMed Web of Science ®Google Scholar
• Mattick, R.P.; Kimber, J.; Breen, C. & Davoli, M. 2008. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database of Systematic Reviews 2: CD002207.
   PubMed Web of Science ®Google Scholar
• McLellan, A.T.; Alterman, A.I.; Cacciola, J.; Metzger, D. & O’Brien, C.P. 1992a. A new measure of substance abuse treatment: Initial studies of the treatment services review. The Journal of Nervous and Mental Disease 180(2): 101–110.
   PubMed Web of Science ®Google Scholar
• McLellan, A.T.; Kushner, H.; Metzger, D.; Peters, R.; Smith, I.; Grissom, G.; Pettinati, H. & Argeriou M. 1992b. The fifth edition of the Addiction Severity Index. Journal of Substance Abuse Treatment 9(3): 199–213.
   PubMed Web of Science ®Google Scholar
• Miller, P.G. & Miller, W.R. 2009. What should we be aiming for in the treatment of addiction? Addiction 104(5): 685–686.
   PubMed Web of Science ®Google Scholar
• Mitchell, S.G.; Gryczynski, J.; Schwartz, R.P.; O’Grady, K.E.; Olsen, Y.K. & Jaffe, J.H. 2013. A randomized trial of intensive outpatient (IOP) vs. standard outpatient (OP) buprenorphine treatment for African Americans. Drug and Alcohol Depend 128(3): 222–229.
   PubMed Web of Science ®Google Scholar
• Noerholm, V.; Groenvold, M.; Watt, T.; Bjorner, J.B.; Rasmussen, N.A. & Bech, P. 2004. Quality of life in the Danish general population: Normative data and validity of WHOQOL-BREF using Rasch and item response theory models. Quality of Life Research 13(2): 531–540.
   PubMed Web of Science ®Google Scholar
• O’Carroll, R.E.; Smith, K.; Couston, M.; Cossar, J.A. & Hayes, P.C. 2000. A comparison of the WHOQOL-100 and the WHOQOL-BREF in detecting change in quality of life following liver transplantation. Quality of Life Research 9(1): 121–124.
   PubMed Web of Science ®Google Scholar
• Padaiga, Z.; Subata, E. & Vanagas, G. 2007. Outpatient methadone maintenance treatment program: Quality of life and health of opioid-dependent persons in Lithuania. Medicina (Kaunas) 43(3): 235–241.
   PubMed Web of Science ®Google Scholar
• Ponizovsky, A.M. & Grinshpoon, A. 2007. Quality of life among heroin users on buprenorphine versus methadone maintenance. The American Journal of Drug and Alcohol Abuse 33(5): 631–642.
   PubMed Web of Science ®Google Scholar
• R Core Team. 2012. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing.
   Google Scholar
• Raisch, D.W.; Campbell, H.M.; Garnand, D.A.; Jones, M.A.; Sather, M.R.; Naik, R. & Ling, W. 2012. Health-related quality of life changes associated with buprenorphine treatment for opioid dependence. Quality of Life Research 21(7): 1177–1183.
   PubMed Web of Science ®Google Scholar
• Ringash, J.; O’Sullivan, B.; Bezjak, A. & Redelmeier, D.A. 2007. Interpreting clinically significant changes in patient-reported outcomes. Cancer 110(1): 196–202.
   PubMed Web of Science ®Google Scholar
• Skevington, S.M.; Lotfy, M.; O’Connell, K.A. & Group, W. 2004. The World Health Organization’s WHOQOL-BREF quality of life assessment: Psychometric properties and results of the international field trial: A report from the WHOQOL group. Quality of Life Research 13(2): 299–310.
   PubMed Web of Science ®Google Scholar
• Tiffany, S.T.; Friedman, L.; Greenfield, S.F.; Hasin, D.S. & Jackson, R. 2012. Beyond drug use: A systematic consideration of other outcomes in evaluations of treatments for substance use disorders. Addiction 107(4): 709–718.
   PubMed Web of Science ®Google Scholar
• Tracy, E.M.; Laudet, A.B.; Min, M.O.; Kim, H.; Brown, S.; Jun, M.K. & Singer, L. 2012. Prospective patterns and correlates of quality of life among women in substance abuse treatment. Drug and Alcohol Depend 124(3): 242–249.
   PubMed Web of Science ®Google Scholar
• Wang, P.W.; Wu, H.C.; Yen, C.N.; Yeh, Y.C.; Chung, K.S.; Chang, H.C. & Yen, C.F. 2012. Change in quality of life and its predictors in heroin users receiving methadone maintenance treatment in Taiwan: An 18-month follow-up study. The American Journal of Drug and Alcohol Abuse 38(3): 213–219.
   PubMed Web of Science ®Google Scholar
• WHOQOL GROUP. 1998. Development of the World Health Organization WHOQOL-BREF quality of life assessment: The WHOQOL Group. Psychological Medicine 28(3): 551–558.
   PubMed Web of Science ®Google Scholar
• World Health Organization. 2004. The World Health Organization Quality of Life (WHOQOL): Bref. Geneva, Switzerland: WHO.
   Google Scholar
• Xiao, L.; Wu, Z.; Luo, W. & Wei, X. 2010. Quality of life of outpatients in methadone maintenance treatment clinics. Journal of Acquired Immune Deficiency Syndromes 53 Suppl 1: S116–120.
   PubMed Web of Science ®Google Scholar
• Zubaran, C. & Foresti, K. 2009. Quality of life and substance use: Concepts and recent tendencies. Current Opinion in Psychiatry 22(3): 281–286.
   PubMed Web of Science ®Google Scholar